Cargando…

Comparison of extracorporeal cellular therapy (ELAD(®)) vs standard of care in a randomized controlled clinical trial in treating Chinese subjects with acute-on-chronic liver failure

BACKGROUND: Preliminary evidence of safety and efficacy of an extracorporeal cellular therapy (ELAD(®)) has been demonstrated in subjects with acute forms of liver failure. This study compared ELAD with standard of care in Chinese subjects with acute-on-chronic liver failure (ACLF), predominantly se...

Descripción completa

Detalles Bibliográficos
Autores principales:	Duan, Zhongping, Xin, Shaojie, Zhang, Jing, You, Shaoli, Chen, Yu, Liu, Hongling, Zheng, Sujun, Li, Zheng, Ashley, Robert, Millis, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Clinical Trial Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6247955/ https://www.ncbi.nlm.nih.gov/pubmed/30532603 http://dx.doi.org/10.2147/HMER.S180246

Ejemplares similares

Extracorporeal cellular therapy (ELAD) in severe alcoholic hepatitis: A multinational, prospective, controlled, randomized trial
por: Thompson, Julie, et al.
Publicado: (2018)

ElaD, a Deubiquitinating Protease Expressed by E. coli
por: Catic, André, et al.
Publicado: (2007)

The effects of extracorporeal shock wave therapy vs hand massage on serum lipids in overweight and obese women
por: Lee, Kyung.Jin, et al.
Publicado: (2021)

Intravenous levosimendan vs. dobutamine in acute decompensated heart failure patients on beta-blockers
por: Bergh, Claes-Håkan, et al.
Publicado: (2010)

Instrumented assisted soft tissue mobilization vs extracorporeal shock wave therapy in treatment of myofascial pain syndrome
por: Shamseldeen, Nourhan Elsayed, et al.
Publicado: (2023)

Lack of association between oral bisphosphonates and osteonecrosis using jaw surgery as a surrogate marker: reply to Yarom and Elad
por: Pazianas, M., et al.
Publicado: (2008)

Serelaxin in addition to standard therapy in acute heart failure: rationale and design of the RELAX‐AHF‐2 study
por: Teerlink, John R., et al.
Publicado: (2017)

Effects of permissive hypocaloric vs standard enteral feeding on gastrointestinal function and outcomes in sepsis
por: Sun, Jia-Kui, et al.
Publicado: (2021)

M2-like macrophages exert hepatoprotection in acute-on-chronic liver failure through inhibiting necroptosis-S100A9-necroinflammation axis
por: Bai, Li, et al.
Publicado: (2021)

Overcoming difficulties with equipoise to enable recruitment to a randomised controlled trial of partial ablation vs radical prostatectomy for unilateral localised prostate cancer
por: Elliott, Daisy, et al.
Publicado: (2018)

Cellular Mechanisms of Hepatoprotection Mediated by M2-Like Macrophages
por: Bai, Li, et al.
Publicado: (2018)

Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer’s disease: study protocol for a randomised controlled trial (ELAD study)
por: Femminella, Grazia Daniela, et al.
Publicado: (2019)

CALIBER: a phase II randomized feasibility trial of chemoablation with mitomycin‐C vs surgical management in low‐risk non‐muscle‐invasive bladder cancer
por: Mostafid, A. Hugh, et al.
Publicado: (2020)

Clinical comparative study assessing the effect of ivabradine on neopterin and NT-Pro BNP against standard treatment in chronic heart failure patients
por: Dogheim, Gaidaa M., et al.
Publicado: (2022)

A dynamic prediction model for prognosis of acute-on-chronic liver failure based on the trend of clinical indicators
por: Yu, Zhenjun, et al.
Publicado: (2021)

Correction to: Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer’s disease: study protocol for a randomised controlled trial (ELAD study)
por: Femminella, Grazia Daniela, et al.
Publicado: (2020)

Development of a Widely Applicable and Simple Prognostic Score for Patients with Acute-on-chronic Liver Failure
por: Yu, Zhenjun, et al.
Publicado: (2022)

Renal function and the effects of vericiguat in patients with worsening heart failure with reduced ejection fraction: insights from the VICTORIA (Vericiguat Global Study in Subjects with HFrEF) trial
por: Voors, Adriaan A., et al.
Publicado: (2021)

Long-term (up to 16 months) health-related quality of life after adjuvant tailored dose-dense chemotherapy vs. standard three-weekly chemotherapy in women with high-risk early breast cancer
por: Brandberg, Yvonne, et al.
Publicado: (2020)

Retrograde inspection vs standard forward view for the detection of colorectal adenomas during colonoscopy: A back-to-back randomized clinical trial
por: Rath, Timo, et al.
Publicado: (2020)

Acute-On-Chronic Liver Failure Defined by Asian Pacific Association for the Study of the Liver Should Include Decompensated Cirrhosis
por: Xu, Manman, et al.
Publicado: (2021)

Zinc carnosine-based modified bismuth quadruple therapy vs standard triple therapy for Helicobacter pylori eradication: A randomized controlled study
por: Ibrahim, Nour, et al.
Publicado: (2022)

The Effect of Extracorporeal Shock Wave Therapy in the Treatment of Patients with Trigger Finger
por: Vahdatpour, Babak, et al.
Publicado: (2020)

Pharmacokinetics of dolutegravir in HIV-seronegative subjects with severe renal impairment
por: Weller, Stephen, et al.
Publicado: (2013)

Safety and Comfort of an Innovative Drug Delivery Device in Healthy Subjects
por: Bertens, Christian J. F., et al.
Publicado: (2020)

Efficacy of antepartum administration of hepatitis B immunoglobulin in preventing mother‐to‐child transmission of hepatitis B virus
por: Zhao, Mengyu, et al.
Publicado: (2019)

Evaluation of Bioequivalency and Pharmacokinetic Parameters for Two Formulations of Glimepiride 1-mg in Chinese Subjects
por: Ju, Gehang, et al.
Publicado: (2020)

Hepatitis B-related acute-on-chronic liver failure induced by hepatotropic viral insult is associated with worse prognosis than that induced by non-virus insult
por: Liang, Jing, et al.
Publicado: (2021)

A novel stem cell therapy for hepatitis B virus-related acute-on-chronic liver failure
por: Zhu, Bing, et al.
Publicado: (2020)

Dyspnoea and worsening heart failure in patients with acute heart failure: results from the Pre-RELAX-AHF study
por: Metra, Marco, et al.
Publicado: (2010)

Patient-directed vs. fixed-volume PEG for colonoscopy preparation: a randomized controlled trial
por: Zhang, Jixiang, et al.
Publicado: (2022)

Switching from rivaroxaban to warfarin: an open label pharmacodynamic study in healthy subjects
por: Moore, Kenneth Todd, et al.
Publicado: (2015)

Modeling‐Based Bone Formation in the Human Femoral Neck in Subjects Treated With Denosumab
por: Dempster, David W, et al.
Publicado: (2020)

Astym treatment vs. eccentric exercise for lateral elbow tendinopathy: a randomized controlled clinical trial
por: Sevier, Thomas L., et al.
Publicado: (2015)

Randomised clinical trial: pre-dosing with taribavirin before starting pegylated interferon vs. standard combination regimen in treatment-naïve patients with chronic hepatitis C genotype 1
por: Palmer, M, et al.
Publicado: (2012)

Association of Hepatitis B Virus Mutations of A1846T and C1913A/G With Acute-on-Chronic Liver Failure Development From Different Underlying Chronic Liver Diseases
por: Zhang, Aimin, et al.
Publicado: (2013)

Exenatide at therapeutic and supratherapeutic concentrations does not prolong the QT(c) interval in healthy subjects
por: Darpö, Börje, et al.
Publicado: (2013)

2322: The effects of fecal microbiota transplantation on the gut microbiota in subjects with Clostridium difficile infection
por: Elizabeth Langdon, Amy, et al.
Publicado: (2018)

Design of the SILICOFCM study: Effect of sacubitril/valsartan vs lifestyle intervention on functional capacity in patients with hypertrophic cardiomyopathy
por: Tafelmeier, Maria, et al.
Publicado: (2020)

Randomized trial on acute toxicities of weekly vs three‐weekly cisplatin‐based chemoradiation in head and neck cancer
por: Ameri, Ahmad, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gqhl7c2ggu69m6vi4reikspqj5